ablative allogeneic hematopoietic cell transplantation

PROCEDURE4 trials

Sponsors

Stanford University

Conditions

Acute DiseaseBlood CancerBlood and Marrow Transplant (BMT)LeukemiaLeukemia, Myeloid, ChronicLymphoma, Non-HodgkinLymphomas: Non-HodgkinMyelodysplastic Syndromes

Phase 2

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

CompletedNCT00186394

Stanford UniversityBlood and Marrow Transplant (BMT), Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin

Start: 2000-04-30End: 2006-12-31Target: 35Updated: 2010-07-27

Unknown Phase

Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors

CompletedNCT00186225

Stanford UniversityBlood and Marrow Transplant (BMT), Blood Cancer

Start: 1989-11-30End: 2010-05-31Target: 250Updated: 2020-04-09

Allo BMT in Advanced Leukemia or High Grade Lymphoma

CompletedNCT00186290

Stanford UniversityBlood and Marrow Transplant (BMT), Leukemia, Lymphoma, Non-Hodgkin +1

Start: 1989-12-31End: 2009-10-31Target: 145Updated: 2010-10-11

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

CompletedNCT00186342

Stanford UniversityAcute Disease, Blood and Marrow Transplant (BMT), Leukemia +4

Start: 1992-09-30End: 2009-01-31Target: 120Updated: 2012-12-17